Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Predictors of Target Lesion Failure in Patients With In-Stent Restenosis: Insights From the AGENT IDE Trial.
Journal: Circulation. Cardiovascular interventions
Published: August 06, 2026
Paclitaxel-Coated Balloon Versus Uncoated Balloon for Coronary In-Stent Restenosis: Two-Year Follow-Up of the AGENT-IDE Randomized Clinical Trial.
Journal: Circulation
Published: July 06, 2026
Impact of Restenosis Pattern on the Safety and Efficacy of Paclitaxel-Coated Balloon Versus Uncoated Balloon for Coronary In-Stent Restenosis.
Journal: Circulation. Cardiovascular interventions
Published: January 26, 2026
Paclitaxel-Coated Balloon for Treating In-Stent Restenosis in Racial and Ethnic Minority Patients: A Subanalysis From the AGENT IDE Trial.
Journal: Journal of the American Heart Association
Published: January 19, 2026
Efficacy and Safety of Paclitaxel-Coated Balloon Angioplasty in Patients With In-Stent Restenosis With vs Without Diabetes.
Journal: Journal of the Society for Cardiovascular Angiography & Interventions
Published: December 02, 2025
Paclitaxel-Coated Balloon for the Treatment of Small Vessel In-Stent Restenosis: A Subgroup Analysis of the AGENT IDE Randomized Trial.
Journal: JACC. Cardiovascular interventions
Published: July 28, 2025
A VEGF gene therapy approach for the treatment of patients with coronary artery disease and refractory angina: assessment of clinical development.
Journal: Expert opinion on investigational drugs
Published: May 27, 2025
Paclitaxel-Coated Balloon for the Treatment of Multilayer In-Stent Restenosis: AGENT IDE Subgroup Analysis.
Journal: Journal of the American College of Cardiology
Published: March 19, 2025
Impeachment Cardiomyopathy: A New Form of Takotsubo
Journal: Journal of cardiac failure
Published: February 06, 2020
Trump Cardiomyopathy: A New Form of Takotsubo Cardiomyopathy.
Journal: Journal of cardiac failure
Published: February 06, 2020
Inflammation and coronary artery disease: from pathophysiology to Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS).
Journal: Coronary artery disease
Published: April 14, 2018
Last Updated: 09/26/2026